Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19

This report describes a case of a male infant diagnosed with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who was prescribed favipiravir therapy. The mother noticed a discoloration of the child's eyes within 18 h of therapy, and the cornea returned to normal color with...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiravisitkul, Paveewan, Thonginnetra, Saraiorn, Wongvisavavit, Rintra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154467/
https://www.ncbi.nlm.nih.gov/pubmed/37152312
http://dx.doi.org/10.3389/fped.2023.1154814
_version_ 1785036128413286400
author Jiravisitkul, Paveewan
Thonginnetra, Saraiorn
Wongvisavavit, Rintra
author_facet Jiravisitkul, Paveewan
Thonginnetra, Saraiorn
Wongvisavavit, Rintra
author_sort Jiravisitkul, Paveewan
collection PubMed
description This report describes a case of a male infant diagnosed with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who was prescribed favipiravir therapy. The mother noticed a discoloration of the child's eyes within 18 h of therapy, and the cornea returned to normal color within 5 days of medication cessation. This case report highlights the need for monitoring of favipiravir therapy in children due to the potential side effect of corneal discoloration, which has not yet had its long-term effects identified.
format Online
Article
Text
id pubmed-10154467
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101544672023-05-04 Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19 Jiravisitkul, Paveewan Thonginnetra, Saraiorn Wongvisavavit, Rintra Front Pediatr Pediatrics This report describes a case of a male infant diagnosed with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who was prescribed favipiravir therapy. The mother noticed a discoloration of the child's eyes within 18 h of therapy, and the cornea returned to normal color within 5 days of medication cessation. This case report highlights the need for monitoring of favipiravir therapy in children due to the potential side effect of corneal discoloration, which has not yet had its long-term effects identified. Frontiers Media S.A. 2023-04-19 /pmc/articles/PMC10154467/ /pubmed/37152312 http://dx.doi.org/10.3389/fped.2023.1154814 Text en © 2023 Jiravisitkul, Thonginnetra and Wongvisavavit. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Jiravisitkul, Paveewan
Thonginnetra, Saraiorn
Wongvisavavit, Rintra
Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19
title Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19
title_full Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19
title_fullStr Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19
title_full_unstemmed Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19
title_short Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19
title_sort case report: favipiravir-induced bluish corneal discoloration in infant with covid-19
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154467/
https://www.ncbi.nlm.nih.gov/pubmed/37152312
http://dx.doi.org/10.3389/fped.2023.1154814
work_keys_str_mv AT jiravisitkulpaveewan casereportfavipiravirinducedbluishcornealdiscolorationininfantwithcovid19
AT thonginnetrasaraiorn casereportfavipiravirinducedbluishcornealdiscolorationininfantwithcovid19
AT wongvisavavitrintra casereportfavipiravirinducedbluishcornealdiscolorationininfantwithcovid19

Ejemplares similares